Fetal biometry showed no clear difference in caesarean delivery compared with maternal glycaemic values (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether fetal biometry changes hypertensive disorders of pregnancy (including pre‐eclampsia,… compared with maternal glycaemic values (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether fetal biometry changes large‐for‐gestational age compared with maternal glycaemic values (very low certainty).
It is very uncertain whether fetal biometry changes shoulder dystocia compared with maternal glycaemic values (very low certainty).
It is very uncertain whether fetal biometry changes composite outcome neonatal morbidity or mortality compared with maternal glycaemic values (very low certainty).
Fetal biometry showed no clear difference in neonatal hypoglycaemia compared with maternal glycaemic values (low certainty).
It is very uncertain whether fetal biometry changes perinatal mortality compared with maternal glycaemic values (very low certainty).
It is very uncertain whether misoprostol changes complete miscarriage compared with expectant care (very low certainty).
Misoprostol may leads to higher unplanned surgical intervention compared with surgery (low certainty).
Misoprostol showed no clear difference in women's views/acceptability of method compared with surgery (moderate certainty).
Misoprostol may leads to higher nausea compared with surgery (low certainty).
Misoprostol probably leads to higher vomiting compared with surgery (moderate certainty).
Misoprostol probably leads to higher diarrhoea compared with surgery (moderate certainty).
Misoprostol showed no clear difference in surgical evacuation compared with expectant care (low certainty).
Misoprostol showed no clear difference in unplanned surgical intervention compared with expectant care (low certainty).